Stanniocalcin, a potential ovarian angiogenesis regulator, does not affect endothelial cell apoptosis

Area of Science:

• Reproductive Biology
• Endocrinology
• Angiogenesis Research

Background:

• Follicular development requires extensive physiological angiogenesis.
• Key factors initiating angiogenesis are known, but mechanisms controlling neovascularization arrest are less understood.
• Stanniocalcin (STC), a protein with an unclear biological role, is investigated for its potential in regulating follicular angiogenesis.

Purpose of the Study:

• To investigate the role of stanniocalcin (STC) in controlling follicular angiogenesis.
• To evaluate STC's effect on vascular endothelial growth factor (VEGF) production by swine granulosa cells.
• To examine STC's impact on endothelial cell viability and caspase activity.

Main Methods:

• Swine granulosa cells were treated with STC (5 and 50 ng/mL) to measure VEGF production.
• Swine aortic endothelial cells were assessed for viability and caspase-3 and -7 activity following STC treatment.

Main Results:

• STC significantly inhibited VEGF production by granulosa cells (P < 0.001).
• STC significantly increased endothelial cell viability (P < 0.001).
• STC significantly reduced caspase-3 and -7 activities in endothelial cells (P < 0.01).

Conclusions:

• STC demonstrates inhibitory effects on VEGF production at the granulosa cell level.
• STC promotes endothelial cell viability and reduces apoptosis, suggesting it is not angiosuppressive.
• STC may modulate local angiogenesis by acting on granulosa cells within the ovarian follicle.